NSE - Delayed Quote INR
Krebs Biochemicals & Industries Limited (KREBSBIO.NS)
78.41
-3.42
(-4.18%)
At close: 3:29:13 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
491,843
504,215
521,344
597,031
386,064
Cost of Revenue
324,410
311,488
423,518
654,674
522,324
Gross Profit
167,433
192,727
97,826
-57,643
-136,260
Operating Expense
359,764
344,684
317,217
337,292
94,158
Operating Income
-192,331
-151,957
-219,391
-394,935
-230,418
Net Non Operating Interest Income Expense
-54,146
-45,327
-27,529
-50,332
-62,069
Pretax Income
-245,178
-197,284
-246,919
-445,268
-283,586
Net Income Common Stockholders
-245,178
-197,284
-246,919
-445,268
-283,586
Diluted NI Available to Com Stockholders
-245,178
-197,284
-246,919
-445,268
-283,586
Basic EPS
-11.38
-9.16
-11.30
-20.81
-14.45
Diluted EPS
-11.38
-9.16
-11.30
-20.81
-14.45
Basic Average Shares
21,564.19
21,560.59
21,560.59
21,560.59
19,620.59
Diluted Average Shares
21,564.19
21,560.59
21,560.59
21,560.59
19,620.59
Rent Expense Supplemental
--
5,788
6,879
6,807
9,425
Total Expenses
684,174
656,172
740,735
991,966
616,482
Net Income from Continuing & Discontinued Operation
-245,178
-197,284
-246,919
-445,268
-283,586
Normalized Income
-245,178
-197,284
-246,919
-445,268
-282,319
Interest Income
--
1,567
2,203
3,578
721
Interest Expense
55,678
46,859
29,710
53,846
62,717
Net Interest Income
-54,146
-45,327
-27,529
-50,332
-62,069
EBIT
-189,500
-150,425
-217,209
-391,422
-220,869
EBITDA
-121,580
-82,762
-151,624
-328,456
-169,630
Reconciled Cost of Revenue
324,410
311,488
423,518
654,674
522,324
Reconciled Depreciation
67,920
67,663
65,585
62,966
51,239
Net Income from Continuing Operation Net Minority Interest
-245,178
-197,284
-246,919
-445,268
-283,586
Total Unusual Items Excluding Goodwill
--
--
--
--
-1,267
Total Unusual Items
--
--
--
--
-1,267
Normalized EBITDA
-121,580
-82,762
-151,624
-328,456
-168,363
3/31/2021 - 10/27/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade